Literature DB >> 6881134

Impaired pentose phosphate shunt function in sickle cell disease: a potential mechanism for increased Heinz body formation and membrane lipid peroxidation.

N A Lachant, W D Davidson, K R Tanaka.   

Abstract

The red cells' antioxidant defense mechanisms were compared between individuals with sickle cell disease and those with hemolytic anemia and reticulocytosis. In sickle cell disease, there was a significant increase in incubated Heinz body formation (p less than .001), a decrease in reduced glutathione concentration (p less than .01), an increase in glucose-6-phosphate dehydrogenase activity (p less than .01), and a decrease in glutathione reductase activity (p less than .005). The patients with sickle cell disease hd an absolute increase in the activity of the pentose shunt in the intact red cell after methylene blue stimulation (p less than .05) and in red cell hemolysates (p less than .0250. Heinz body formation (r = .75) and pentose shunt activity in red cell hemolysates (r = .83) were strongly related to the degree of reticulocytosis. Although there was a correlation between the pentose shunt activity in the stimulated red cell and in red cell hemolysates for the patients with hemolytic anemia (r = .58), stimulated shunt activity did not increase as the hemolysate shunt activity increased for the patients with sickle cell disease. There were very strong relationships between the ATP concentration and the reticulocyte count (r = .80) and the hemolysate pentose shunt activity (r = .77) in sickle cel disease. These data suggest that in spite of an absolute increase in stimulated pentose shunt activity, there Is a relative suppression of stimulated shunt activity in the youngest sickle erythrocytes. This may be related, in part, to the inhibitory effects of high concentrations of ATP on the activity of glucose-6-phosphate dehydrogenase.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6881134     DOI: 10.1002/ajh.2830150102

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  11 in total

1.  Biochemical indicator of sickle cell disease: preliminary report from India.

Authors:  S Pandey; A Sharma; S Dahia; V Shah; V Sharma; R M Mishra; Sw Pandey; R Saxena
Journal:  Indian J Clin Biochem       Date:  2011-09-25

2.  Increased oxidative stress alters nucleosides metabolite levels in sickle cell anemia.

Authors:  Lívia Gelain Castilhos; Juliana Sorraila de Oliveira; Stephen Adeniyi Adefegha; Luana Pereira Magni; Pedro Henrique Doleski; Fatima Husein Abdalla; Cínthia Melazzo de Andrade; Daniela Bitencourt Rosa Leal
Journal:  Redox Rep       Date:  2017-02-16       Impact factor: 4.412

3.  Impaired vasodilation by red blood cells in sickle cell disease.

Authors:  John R Pawloski; Douglas T Hess; Jonathan S Stamler
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-07       Impact factor: 11.205

4.  Asthma in children with sickle cell disease and its association with acute chest syndrome.

Authors:  J M Knight-Madden; T S Forrester; N A Lewis; A Greenough
Journal:  Thorax       Date:  2005-03       Impact factor: 9.139

5.  Effect of 1-chloro-2,4-dinitrobenzene on K+ transport in normal and sickle human red blood cells.

Authors:  M C Muzyamba; J S Gibson
Journal:  J Physiol       Date:  2003-02-07       Impact factor: 5.182

Review 6.  Cellular metabolic and autophagic pathways: traffic control by redox signaling.

Authors:  Matthew Dodson; Victor Darley-Usmar; Jianhua Zhang
Journal:  Free Radic Biol Med       Date:  2013-05-20       Impact factor: 7.376

7.  Erythrocyte glutamine depletion, altered redox environment, and pulmonary hypertension in sickle cell disease.

Authors:  Claudia R Morris; Jung H Suh; Ward Hagar; Sandra Larkin; D Anton Bland; Martin H Steinberg; Elliott P Vichinsky; Mark Shigenaga; Bruce Ames; Frans A Kuypers; Elizabeth S Klings
Journal:  Blood       Date:  2007-09-11       Impact factor: 22.113

Review 8.  Sickle Cell Disease: Advances in Treatment.

Authors:  Renée V Gardner
Journal:  Ochsner J       Date:  2018

9.  A posttranslational modification of beta-actin contributes to the slow dissociation of the spectrin-protein 4.1-actin complex of irreversibly sickled cells.

Authors:  A Shartava; C A Monteiro; F A Bencsath; K Schneider; B T Chait; R Gussio; L A Casoria-Scott; A K Shah; C A Heuerman; S R Goodman
Journal:  J Cell Biol       Date:  1995-03       Impact factor: 10.539

10.  Aged garlic extract therapy for sickle cell anemia patients.

Authors:  Junichiro Takasu; Rolando Uykimpang; Maria Sunga; Harunobu Amagase; Yutaka Niihara
Journal:  BMC Blood Disord       Date:  2002-06-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.